1995 – present Association for Research in Vision and Ophthalmology (ARVO)
1999 – present American Academy of Ophthalmology
2005 - present Austrian Scientists in North America (ASCINA)
2007 – present North American NeuroOphthalmology Society (NANOS)
2007 – 2008 Maryland Society of Eye Physicians and Surgeons
2007 – 2008 The Maryland State Medical Society (Med Chi)
2007 – 2008 Baltimore City Medical Society Honors and Awards 1994 Kurt Gödel scholarship for postgraduate research abroad.
Ministry of Science, Austria
2007 Attending of the year – University of Maryland School of Medicine, Department of Ophthalmology
Clinical Activities 2004 - present Clinical practice at University of Maryland Faculty Physicians, Inc.
2004 - present Attending Physician, Baltimore VA Hospital
2004 - 2009 Ophthalmology Consultant, The Joslin Diabetes Center
University of Maryland Medical Center
500 patient visits / year
2006 - present Director, Ophthalmology Consult Service
University of Maryland Medical Center
Board certified Ophthalmologist, Subspecialty fellowship training in Neuroophthalmology.
Expertise in optic neuropathies (congenital, ischemic, compressive, demyelinating, inflammatory, traumatic), ocular motility disorders, disorders of higher visual functions, disorders of ocular innervation, idiopathic intracranial hypertension, systemic diseases, central nervous system disorders, tumors, and other malignancies affecting ocular motility and function,
Scope of Clinical Practice
Primary practice site: University of Maryland Eye Physicians
419 W Redwood St.
Satellite offices: 20, Crossroads Drive
Owings Mills, MD
Other sites: University of MD Medical Center
S Greene St, Baltimore, MD
Baltimore, VA Medical Center
N Greene St., Baltimore, MD
(starting 2017) University of MD Rehabilitation and Orthopedic Institute
Kernan Drive, Baltimore, MD
Total number of patients/week: 40
Number of referrals received/week: 25
Responsibilities with practice: Director, Neuroophthalmology service
Director, Consult Service
Physician Compliance Liaison
EPIC / Portfolio Physician Champion
Portfolio Inpatient Physician Champion
Grand Rounds Committee
Total time spent in clinical duties: 35
Recent Innovations that have influenced practice:
Optical Coherence Tomography: Recent advances in image quality and imaging analysis software allow detailed analysis of optic nerve abnormalities and longitudinal follow-up.
Cancer therapy: New innovative treatment strategies, such as proton beam therapy, have significantly increased individual survival rates and lead to more patients presenting with complex neuroophthalmologic complications of their cancer of treatment side-effects.
2010 – 2015 Participating Investigator: A double-blind, placebo-controlled study to evaluate new or worsening lens opacification in subjects with non-metastatic prostate cancer receiving Denosumab for bone loss due to Androgen-deprivation therapy.
Protocol 20080560; Sponsor: Amgen, Inc. Time commitment: 2 %
2015 – present Participating Investigator: A Phase 2/3, Double-masked, Placebo-controlled Study with Open-label Extension to Evaluate the Safety and Efficacy of MEDI-551 in Adult Subjects with Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
Sponsor: Medimmune , Inc. Time commitment: 2%
2015 – present Participating Investigator: Long term, prospective, multinational, parallel-cohort study monitoring safety in patients with MS newly started on fingolimod once daily or treated with another approved disease-modifying therapy. (CFTY720D2403) Sponsor: Medimmune, Inc. Time commitment: 2%
Spinal fluid leak after chiropractic manipulation of the cervical spine.
Arch Ophthalmol 2006; 124(2): 283
7. RR Sayegh, KA Madsen, JD Adler, MA Johnson, MK Mathews: Diffuse retinal injury from a non-penetrating TASER dart. Documenta Ophthalmologica 2011; 123 (2): 135-139
8. RR Sayegh, KA Madsen, JD Adler, MA Johnson, MK Mathews: Response to TASER electronic control devices and eye injuries. Documenta Ophthalmologica 2012 Apr;124(2):161-2
9. N Bhatt, R Morales, M Mathews: MRI Findings in Bilateral Post-operative Posterior Ischemic Optic Neuropathy. Open Journal of Ophthalmology. 2013, 3, 51-53. http://dx.doi.org/10.4236/ojoph.2013.33013
10. Mathews M, Albukh T, Duncan K. Early ocular lipid deposition in a mouse model of hyperlipidemia and atherosclerosis. Invest Ophthalmol Vis Sci. 2013;54(15):4104-4104.
11. MK Mathews, Y Guo, P Langenberg, SL Bernstein. Ciliary neurotrophic factor (CNTF) - mediated ganglion cell survival in a rodent model of non-arteritic anterior ischaemic optic neuropathy (NAION). Br J Ophthalmol., 2015;99:133-137 doi:10.1136/bjophthalmol-2014-305969
12. E Couser, SL Bernstein, MK Mathews. Effect of Alzheimer's Disease on Melanopsin Expression in the Lateral Geniculate Nucleus. Invest. Ophthalmol. Vis. Sci. 2015;56(7):5561.
13. MA Malouf, R Levin, MK Mathews. Leber’s Hereditary Optic Neuropathy - Not just a young men’s disease. J Am Geriatr Soc 2016; 64(1): 232. AID JGS13899.
Non-peer-reviewed journal articles
1. MK Mathews, RC Sergott, PJ Savino
Curr Opin Ophthalmol 2003; 14(6): 364-370.
Reprinted in Contemporary Ophthalmology 2004; 25(3). Review
2. MK Mathews
Nonarteritic anterior ischemic optic neuropathy.
Curr Opin Ophthalmol. 2005; 16(6):341-5. Review
Abstracts and/or Proceedings
1. M Kunz, CA Merges, DS McLeod, GA Lutty
Effects of adenosine on canine retinal capillary endothelial cell migration and vascular cord formation.